INGEN BIO ADMINISTRATION
IngenBio is your source of unprecedented intelligence capability for tracking transmutational activity and pharmaceutical effectiveness in real time by measuring transmutational response and patient behavior.
Chairman of the Board, CEO and President, Ingen Bio - Dr. Harlan Griffin
CEO / Chairman and founder, Dr. Harlan Griffin - has been Ingen's Chief Executive Officer and President since 1985 and has been Chairman of the company's Board of Directors since 1987. Griffin's support for the BioIndustry Initiative - English Language and Nonproliferation Program, has introduced top Russian scientists to the Ingen Bio team - including Ingen Partner and former Soviet Scientist Dr. Leonard Kendall, Head Scientist for the Soviet State Research Center for Applied Microbiology (GosNIIPM).
Ingen Bio Corporation strongly supports the ISTC Partner Program, BII-ELAN, and the Institute of Medicine and National Research Council of the National Academies.
IngenBio also follows the ENVIRONMENTAL PROTECTION AGENCYOPP-2003-0132; FRL-7302-8
Proposed Rulemaking: http://www.epa.gov/EPA-GENERAL/2003/May/Day-07/g11002.htm
USAMRIID Support
Technology Transfer Alliance (TTA) is a collaborative process benefiting IngenBio and USAMRIID. The evolution of TTA since 1992 has made it increasingly easier for USAMRIID laboratory scientists to bring funding, personnel, information, and resources into the USAMRIID community from outside sources through participation in the process. Outside sources may also realize these same benefits from the Command although government funding is strictly limited to specific arrangements when they participate in the process.
Mechanisms: IngenBio is an important partner with testing, industry, and other eligible entities in this process and utilizes a number of mechanisms for establishing the essential collaborative relationship.
Critical Intervention in Technology Transfer
Cooperative Research and Development efforts, especially CITTA, have the greatest potential for long-term payoff of any TTA mechanism. They allow IngenBio scientists to better understand the technology needs of the commercial sector and facilitate a reverse flow of ideas, resources, and funds into the laboratories and are the linchpins of the Command’s technology transfer program.
The CRADA agreement between one or more federal laboratories and IngenBio under which we provide personnel, facilities, or other resources and the nonfederal parties provide funds, personnel, services, facilities, equipment, or other resources to conduct specific research or development efforts that are consistent with the laboratory’s mission.
Steps:
Legislative History
1986
1986
1992
1995